about
Novel insights into the downstream pathways and targets controlled by transcription factors CREM in the testisCharacterization of chemically induced ovarian carcinomas in an ethanol-preferring rat model: influence of long-term melatonin treatmentHigh prevalence of breast cancer in light polluted areas in urban and rural regions of South Korea: An ecologic study on the treatment prevalence of female cancers based on National Health Insurance data.What is known about melatonin, chemotherapy and altered gene expression in breast cancerMelatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancerMelatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cellsFirst-morning urinary melatonin and breast cancer risk in the Guernsey StudySeasonal variation in children with developmental dysplasia of the hip.Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review).Melatonin: a "Higgs boson" in human reproduction.Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma.Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells.Melatonin interferes in the desmoplastic reaction in breast cancer by regulating cytokine production.Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer.Melatonin promotes differentiation of 3T3-L1 fibroblasts.Exposure to road traffic and railway noise and postmenopausal breast cancer: A cohort study.Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction.Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair.Expression of MT2 receptor in patients with gastric adenocarcinoma and its relationship with clinicopathological features.Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers
P2860
Q27308857-55C6C4B2-4652-4299-B0F0-E5FB4517C911Q28537709-A7BB2986-CF4D-45ED-B974-63409104E83FQ30947207-CA226704-E5F2-49BF-B365-CE21FD1B3629Q33597963-B2F1B2AF-801D-4B2A-B9AF-A1D3155EAB2EQ35066004-11CA7AE1-CD94-4903-9C79-108B843365FAQ37424009-F9B20E15-FFA7-4F17-9B25-27777547130DQ37591161-D97E41D3-6007-4FF7-AC99-5E01CAD6CC65Q37603660-23B5C97D-73E7-4234-81D2-27BDA9CE4404Q38002452-F9D3E098-F103-4DA3-9107-5D85C9433A57Q38221495-F51935A0-DE92-4E7E-8C54-B0576A286AB3Q38265922-BCEB525B-B2C2-4AA8-8281-E64728AF6E85Q39208543-99C9B6D0-67E1-43F9-AF69-4D03B3AA4D7DQ39271087-4ED6C518-F84A-4741-88E9-D9694AD03E1AQ39431604-009C4D8B-7FE9-4B9F-A5C0-3A9BA94F9B84Q39496459-334F2E68-1D45-4232-B7C8-1F0AFD35AFD7Q42808778-A85F644A-7C19-45CA-BE1A-01411537385BQ43457861-397E10EF-EC71-48CB-A571-8FF4CF481173Q48208724-8B7D21CC-ABE3-4E2D-ADB2-9D264329A092Q52972430-DBBBF414-C7B8-4EE5-A06D-877B1B8011FFQ54238714-A8C0523E-4943-4102-AF3C-1EA1A18B4743Q58587207-889F8E4A-6993-4E77-A49D-E2B740D4387F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Melatonin as a selective estrogen enzyme modulator.
@en
Melatonin as a selective estrogen enzyme modulator.
@nl
type
label
Melatonin as a selective estrogen enzyme modulator.
@en
Melatonin as a selective estrogen enzyme modulator.
@nl
prefLabel
Melatonin as a selective estrogen enzyme modulator.
@en
Melatonin as a selective estrogen enzyme modulator.
@nl
P50
P1476
Melatonin as a selective estrogen enzyme modulator
@en
P2093
A González
M D Mediavilla
P304
P356
10.2174/156800908786733469
P577
2008-12-01T00:00:00Z